Increased Levels of Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor‐1 in Ischemic Stroke and Transient Ischemic Attack
暂无分享,去创建一个
Pål Aukrust | P. Aukrust | K. Otterdal | A. Aamodt | C. Dahl | B. Halvorsen | K. Skagen | M. Skjelland | K. Krohg‐Sørensen | Tonje Skarpengland | Mona Skjelland | Xiang Yi Kong | Karolina Skagen | Sverre Holm | Kari Otterdal | Christen P. Dahl | Kirsten Krohg‐Sørensen | Ellen L. Sagen | Vigdis Bjerkeli | Anne Hege Aamodt | Azhar Abbas | Ida Gregersen | Bente Halvorsen | Tuva B. Dahl | T. Dahl | I. Gregersen | E. L. Sagen | V. Bjerkeli | Azhar Abbas | X. Kong | T. Skarpengland | S. Holm | Ida Gregersen
[1] M. Lazar,et al. PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1. , 2005, The Journal of clinical investigation.
[2] V. Chair,et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.
[3] S. Miyamoto,et al. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. , 1999, Circulation.
[4] T. Hirai,et al. LOX-1 pathway affects the extent of myocardial ischemia-reperfusion injury. , 2003, Biochemical and biophysical research communications.
[5] T. Kita,et al. Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[6] Lin Xie,et al. LOX-1 expression and oxidized LDL uptake and toxicity in the HN33 neuronal cell line , 2014, Neuroscience Letters.
[7] Zi-wen Zhao,et al. Circulating Soluble Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor‐1 Levels Are Associated With Angiographic Coronary Lesion Complexity in Patients With Coronary Artery Disease , 2011, Clinical cardiology.
[8] A. Çelik,et al. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels predict percutaneous coronary intervention-related periprocedural myocardial infarction in stable patients undergoing elective native single-vessel PCI , 2012, Journal of Thrombosis and Thrombolysis.
[9] Y. Kokubo,et al. High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age- and Sex-Matched Cross-Sectional Study , 2016, Journal of atherosclerosis and thrombosis.
[10] R Eugene Zierler,et al. Carotid artery stenosis: gray-scale and Doppler US diagnosis--Society of Radiologists in Ultrasound Consensus Conference. , 2003, Radiology.
[11] T. Sawamura,et al. Expression of LOX-1, an oxidized low-density lipoprotein receptor, in experimental hypertensive glomerulosclerosis. , 2000, Journal of the American Society of Nephrology : JASN.
[12] K. Jin,et al. Soluble lectin-like oxidized low-density lipoprotein receptor-1 as a novel biomarker for large-artery atherosclerotic stroke , 2017, The International journal of neuroscience.
[13] Takeshi Kimura,et al. Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels Are Elevated in Acute Coronary Syndrome: A Novel Marker for Early Diagnosis , 2005, Circulation.
[14] P. Aukrust,et al. High Levels of S100A12 Are Associated With Recent Plaque Symptomatology in Patients With Carotid Atherosclerosis , 2012, Stroke.
[15] T. Kita,et al. Identification of soluble forms of lectin-like oxidized LDL receptor-1. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[16] M. Bots,et al. Atherosclerotic Plaque Vulnerability as an Explanation for the Increased Risk of Stroke in Elderly Undergoing Carotid Artery Stenting , 2011, Stroke.
[17] Carotid artery plaque composition--relationship to clinical presentation and ultrasound B-mode imaging. European Carotid Plaque Study Group. , 1995, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[18] Magda Gioia,et al. Membrane Cholesterol Modulates LOX-1 Shedding in Endothelial Cells , 2015, PloS one.
[19] S. Lorkowski,et al. Proinflammatory Cytokines Regulate LOX-1 Expression in Vascular Smooth Muscle Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[20] Yue Deng,et al. Losartan attenuated lipopolysaccharide-induced lung injury by suppression of lectin-like oxidized low-density lipoprotein receptor-1. , 2015, International journal of clinical and experimental pathology.
[21] T. Aoyama,et al. LOX‐1 mediates lysophosphatidylcholine‐induced oxidized LDL uptake in smooth muscle cells , 2000, FEBS letters.
[22] Yin-gang Ren,et al. Postprocedural serum sLOX-1 levels are associated with coronary in-stent restenosis in patients with stable coronary artery disease , 2011, Coronary artery disease.
[23] S. Narumiya,et al. Increased Expression of Lectinlike Oxidized Low Density Lipoprotein Receptor-1 in Initial Atherosclerotic Lesions of Watanabe Heritable Hyperlipidemic Rabbits , 2000 .
[24] Nobuaki Kobayashi,et al. Soluble lectin-like oxidized LDL receptor-1 and high-sensitivity troponin T as diagnostic biomarkers for acute coronary syndrome. Improved values with combination usage in emergency rooms. , 2011, Circulation journal : official journal of the Japanese Circulation Society.
[25] T. Sawamura,et al. Activation-dependent surface expression of LOX-1 in human platelets. , 2001, Biochemical and biophysical research communications.
[26] M. Lazar,et al. PPARγ regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1 , 2005 .
[27] C. Zhang,et al. CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzyme , 2011, Journal of Lipid Research.
[28] A. Catapano,et al. Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases , 2013, Disease markers.
[29] Y. Kokubo,et al. LOX index, a novel predictive biochemical marker for coronary heart disease and stroke. , 2010, Clinical chemistry.
[30] G. Norata,et al. LOX-1, OxLDL, and Atherosclerosis , 2013, Mediators of inflammation.
[31] T. Kita,et al. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome--a pilot study. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[32] R. Lorenz,et al. The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin. , 1999, Biochemical pharmacology.
[33] T. Kita,et al. Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome--comparison with other biomarkers. , 2010, Journal of cardiology.
[34] H. Kosaka,et al. Induction of LOX‐1 and iNOS expressions by ischemia‐reperfusion of rat kidney and the opposing effect of L‐arginine , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[35] T. Kita,et al. Interleukin 18 stimulates release of soluble lectin-like oxidized LDL receptor-1 (sLOX-1). , 2009, Atherosclerosis.
[36] T. Sawamura,et al. Inducible Expression of LOX‐1, a Novel Receptor for Oxidized LDL, in Macrophages and Vascular Smooth Muscle Cells , 2000, Annals of the New York Academy of Sciences.
[37] T. Sawamura,et al. The Discovery of LOX-1, its Ligands and Clinical Significance , 2011, Cardiovascular Drugs and Therapy.